Big Data Analytics, Infectious Diseases and Associated Ethical Impacts.
Big data analytics
Ethics
Infectious diseases
Mobile phones
Wearables
Journal
Philosophy & technology
ISSN: 2210-5433
Titre abrégé: Philos Technol
Pays: Netherlands
ID NLM: 101583724
Informations de publication
Date de publication:
2019
2019
Historique:
received:
24
02
2017
accepted:
02
08
2017
entrez:
27
4
2019
pubmed:
27
4
2019
medline:
27
4
2019
Statut:
ppublish
Résumé
The exponential accumulation, processing and accrual of big data in healthcare are only possible through an equally rapidly evolving field of big data analytics. The latter offers the capacity to rationalize, understand and use big data to serve many different purposes, from improved services modelling to prediction of treatment outcomes, to greater patient and disease stratification. In the area of infectious diseases, the application of big data analytics has introduced a number of changes in the information accumulation models. These are discussed by comparing the traditional and new models of data accumulation. Big data analytics is fast becoming a crucial component for the modelling of transmission-aiding infection control measures and policies-emergency response analyses required during local or international outbreaks. However, the application of big data analytics in infectious diseases is coupled with a number of ethical impacts. Four key areas are discussed in this paper: (i) automation and algorithmic reliance impacting freedom of choice, (ii) big data analytics complexity impacting informed consent, (iii) reliance on profiling impacting individual and group identities and justice/fair access and (iv) increased surveillance and population intervention capabilities impacting behavioural norms and practices. Furthermore, the extension of big data analytics to include information derived from personal devices, such as mobile phones and wearables as part of infectious disease frameworks in the near future and their potential ethical impacts are discussed. Considered together, the need for a constructive and transparent inclusion of ethical questioning in this rapidly evolving field becomes an increasing necessity in order to provide a moral foundation for the societal acceptance and responsible development of the technological advancement.
Identifiants
pubmed: 31024785
doi: 10.1007/s13347-017-0278-y
pii: 278
pmc: PMC6451937
doi:
Types de publication
Journal Article
Langues
eng
Pagination
69-85Références
Geoforum. 2016 Oct;75:253-264
pubmed: 32287362
BMC Public Health. 2005 Dec 22;5:141
pubmed: 16372902
Health Inf Sci Syst. 2014 Feb 07;2:3
pubmed: 25825667
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):15888-93
pubmed: 25349388
Ecohealth. 2016 Mar;13(1):200-12
pubmed: 26915507
Am J Prev Med. 2010 Jul;39(1):78-80
pubmed: 20537846
N Engl J Med. 2014 Oct 16;371(16):1481-95
pubmed: 25244186
J Clin Microbiol. 2012 Apr;50(4):1461-3
pubmed: 22301026
N Engl J Med. 2009 Jul 9;361(2):212-4
pubmed: 19564630
Health Psychol. 2006 Jan;25(1):82-90
pubmed: 16448301
BMJ. 1994 Jul 16;309(6948):184-8
pubmed: 8044100
Science. 2016 Jun 24;352(6293):1522-3
pubmed: 27339972
Clin Infect Dis. 2015 Dec 1;61(11):1695-702
pubmed: 26251049
J Infect Dis. 2016 Dec 1;214(suppl_4):S409-S413
pubmed: 28830109
PLoS Pathog. 2014 Jun 26;10(6):e1004206
pubmed: 24968312
Vaccine. 2010 Aug 23;28(37):6058-64
pubmed: 20620167
Bull World Health Organ. 2009 Aug;87(8):619-23
pubmed: 19705013
Ochsner J. 2015 Spring;15(1):5-7
pubmed: 25829872
Euro Surveill. 2010 Dec 16;15(50):
pubmed: 21172175
Emerg Infect Dis. 2003 Oct;9(10):1197-204
pubmed: 14609452
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6872-7
pubmed: 19332788
Global Health. 2006 May 23;2:9
pubmed: 16719925
Lancet. 2009 Nov 21;374(9703):1786-91
pubmed: 19914707
PLoS One. 2013 Sep 11;8(9):e73970
pubmed: 24040129
BMC Public Health. 2010 Jan 21;10:31
pubmed: 20092624
Lancet. 2015 May 9;385(9980):1910-2
pubmed: 25987159
Emerg Infect Dis. 2009 May;15(5):689-95
pubmed: 19402953
Artif Intell Med. 2012 Nov;56(3):137-56
pubmed: 23122689
J Med Internet Res. 2015 Jun 29;17(6):e161
pubmed: 26123476
Appl Environ Microbiol. 2016 Jun 30;82(14):4081-4089
pubmed: 27129960
Biopreserv Biobank. 2016 Oct;14(5):450-451
pubmed: 27249183
F1000Res. 2015 Feb 12;4:43
pubmed: 25789162
Lancet. 2015 May 9;385(9980):1884-901
pubmed: 25987157
Sci Rep. 2016 Aug 26;6:31456
pubmed: 27562273
BMJ. 2009 Sep 03;339:b3471
pubmed: 19729419
J Biomed Inform. 2015 Jun;55:272-89
pubmed: 25917056
PLoS Med. 2005 Jan;2(1):e6
pubmed: 15696216
JAMA. 2013 Apr 3;309(13):1351-2
pubmed: 23549579
PLoS One. 2014 Dec 05;9(12):e114306
pubmed: 25478915
Mil Med. 2000 Aug;165(8):ii-iii
pubmed: 10957845
Sci Eng Ethics. 2018 Feb;24(1):1-28
pubmed: 28155094
Sex Transm Infect. 2017 Jun;93(4):234-235
pubmed: 27884965
EMBO Rep. 2008 Jul;9 Suppl 1:S13-7
pubmed: 18578017
Lancet Infect Dis. 2001 Dec;1(5):345-53
pubmed: 11871807
Sci Eng Ethics. 2016 Apr;22(2):303-41
pubmed: 26002496
Euro Surveill. 2006;11(12):234-8
pubmed: 17370965
Geospat Health. 2008 May;2(2):215-25
pubmed: 18686270
BMC Med Ethics. 2012 May 20;13:10
pubmed: 22606995
BMJ. 2016 Jul 08;354:i3814
pubmed: 27401324
Camb Q Healthc Ethics. 2015 Jul;24(3):281-92
pubmed: 26059954
J Infect Dis. 2016 Dec 1;214(suppl_4):S380-S385
pubmed: 28830112
Science. 2014 Mar 14;343(6176):1203-5
pubmed: 24626916
Emerg Infect Dis. 2016 Mar;22(3):538-40
pubmed: 26891363
Euro Surveill. 2006;11(12):239-42
pubmed: 17370964
Proc Biol Sci. 2015 Nov 7;282(1818):20150814
pubmed: 26511046
BMJ Open. 2014 Sep 08;4(9):e006021
pubmed: 25200561
Emerg Infect Dis. 2004 May;10(5):858-64
pubmed: 15200820